Postsynaptic production of nitric oxide implicated in long-term depression at the mature amphibian (Bufo marinus) neuromuscular junction

Journal of Physiology

Volumn 559, Issue 2, 2004, Pages 507-517

  Etherington, Sarah J ^a   Everett, Alan W ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; 2 (4 CARBOXYPHENYL) 4,4,5,5 TETRAMETHYLIMIDAZOLINE 1 OXYL 3 OXIDE; CALCINEURIN; CALCINEURIN INHIBITOR; CALCIUM ION; CALMODULIN INHIBITOR; CHOLINERGIC RECEPTOR; CYCLIC GMP; CYCLIC GMP DEPENDENT PROTEIN KINASE INHIBITOR; CYCLOSPORIN A; DANTROLENE; GUANYLATE CYCLASE INHIBITOR; N(G) NITROARGININE METHYL ESTER; NEUROTRANSMITTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; PHENOXYBENZAMINE; SCAVENGER; TACROLIMUS; CALMODULIN; CYCLIC GMP DEPENDENT PROTEIN KINASE; GUANYLATE CYCLASE;

AMPHIBIA; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CALCIUM TRANSPORT; CONTROLLED STUDY; ENDPLATE POTENTIAL; INHIBITION KINETICS; LONG TERM DEPRESSION; MINIATURE ENDPLATE POTENTIAL; MUSCLE CONTRACTION; NERVE CELL; NERVE STIMULATION; NEUROMUSCULAR SYNAPSE; NEUROTRANSMITTER RELEASE; NONHUMAN; POSTSYNAPTIC MEMBRANE; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; SARCOPLASMIC RETICULUM; SCHWANN CELL; SIGNAL TRANSDUCTION; SYNAPSE; SYNAPTIC TRANSMISSION; TOAD; BUFO MARINUS;

ANIMALS; BUFO MARINUS; ELECTRIC STIMULATION; LONG-TERM DEPRESSION (PHYSIOLOGY); NEUROMUSCULAR JUNCTION; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; SYNAPTIC TRANSMISSION;

EID: 4644357530     PISSN: 00223751     EISSN: None     Source Type: Journal    
DOI: 10.1113/jphysiol.2004.066498     Document Type: Article

References (46)

1. Aonuma H, Nagayama T & Takahata M (2000). Modulatory effects of nitric oxide on synaptic depression in the crayfish neuromuscular system. J Exp Biol 203, 3595-3602.
2. Bennett MR & Lavidis NA (1991). Probabilistic secretion of quanta from the release sites of nerve terminals in amphibian muscle modulated by seasonal changes. Neurosci Lett 134, 79-82.
3. Bredt DS, Ferris CD & Snyder SH (1992). Nitric oxide synthase regulatory sites. Phosphorylation by cyclic AMP-dependent protein kinase, protein kinase C, and calcium/calmodulin protein kinase; Identification of flavin and calmodulin binding sites. J Biol Chem 267, 10976-10981.
4. Bredt D & Snyder S (1990). Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc Natl Acad Sci U S A 87, 682-685.
5. Cash S, Dan Y, Poo M-M & Zucker RS (1996). Postsynaptic elevation of calcium induces persistent depression of neuromuscular synapses. Neuron 16, 745-754.
6. Chao DS, Silvagno F, Xia H, Cornwell TL, Lincoln TM & Bredt DS (1996). Nitric oxide synthase and cyclic GMP-dependent protein kinase concentrated at the neuromuscular endplate. Neuroscience 76, 665-672.
7. Dawson T, Steiner J, Dawson V, Dinerman J, Uhl G & Snyder S (1993). Immunosuppressant FK506 enhances phosphorylation of nitric oxide synthase and protects against glutamate neurotoxicity. Proc Natl Acad Sci U S A 90, 9808-9812.
8. Descarries LM, Cai S & Robitaille R (1998). Localization and characterization of nitric oxide synthase at the frog neuromuscular junction. J Neurocytol 27, 829-840.
9. Esplugues JV (2002). NO as a signalling molecule in the nervous system. Br J Pharmacol 135, 1079-1095.
10. Feelisch M, Kotsonis P, Siebe J, Clement B & Schmidt HH (1999). The soluble guanylyl cyclase inhibitor 1H-[1,2,4]oxadiazolo[4,3,-a] quinoxalin-1-one is a nonselective heme protein inhibitor of nitric oxide synthase and other cytochrome P-450 enzymes involved in nitric oxide donor bioactivation. Mol Pharmacol 56, 243-253.
11. Garthwaite J & Boulton CL (1995). Nitric oxide signaling in the central nervous system. Annu Rev Physiol 57, 683-706.
12. Garthwaite J, Southam E, Boulton CL, Nielsen EB, Schmidt K & Mayer B (1995). Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]oxadiazolo [4,3-a] quinoxalin-1-one. Mol Pharmacol 48, 184-188.
13. Gath I, Closs EI, Godtel-Armbrust U, Schmitt S, Nakane M, Wessler I & Forstermann U (1996). Inducible NO synthase II and neuronal NO synthase I are constitutively expressed in different structures of guinea pig skeletal muscle: implications for contractile function. FASEB J 10, 1614-1620.
14. 2+ mobilization in the mouse diaphragm muscle. Neurosci Lett 180, 101-104.
15. Knowles RG, Palacios M, Palmer RM & Moncada S (1989). Formation of nitric oxide from 1-arginine in the central nervous system: a transduction mechanism for stimulation of the soluble guanylate cyclase. Proc Natl Acad Sci U S A 86, 5159-5162.
16. Ko GY & Kelly PT (1999). Nitric oxide acts as a postsynaptic signaling molecule in calcium/calmodulin-induced synaptic potentiation in hippocampal CA1 pyramidal neurons. J Neurosci 19, 6784-6794.
17. Kobzik L, Reid MB, Bredt DS & Stamler JS (1994). Nitric oxide in skeletal muscle. Nature 372, 546-548.
18. Komeima K & Watanabe Y (2001). Dephosphorylation of nNOS at Ser847 by protein phosphatase 2A. FEBS Lett 497, 65-66.
19. Kusner LL & Kaminski HJ (1996). Nitric oxide synthase is concentrated at the skeletal muscle endplate. Brain Res 730, 238-242.
20. Li S-T, Kato K, Tomizawa K, Matsushita M, Moriwaki A, Matsui H & Mikoshiba K (2002). Calcineurin plays different roles in group II metabotropic glutamate receptor- and NMDA receptor-dependent long-term depression. J Neurosci 22, 5034-5041.
21. Linden DJ & Connor JA (1992). Long-term depression of glutamate currents in cultured cerebellar purkinje neurons does not require nitric oxide signalling. Eur J Neurosci 4, 10-15.
22. Lindgren CA & Laird MV (1994). Nitroprusside inhibits neurotransmitter release at the frog neuromuscular junction. Neuroreport 5, 2205-2208.
23. Mulkey RM, Endo S, Shenolikar S & Malenka RC (1994). Involvement of a calcineurin/inhibitor-1 phosphatase cascade in hippocampal long-term depression. Nature 369, 486-488.
24. Nakane M, Schmidt HHHW, Pollock JS, Forstermann U & Murad F (1993). Cloned human brain nitric oxide synthase is highly expressed in skeletal muscle. FEBS Lett 316, 175-180.
25. Prast H & Philippu A (2001). Nitric oxide as modulator of neuronal function. Prog Neurobiol 64, 51-68.
26. Prior C & Singh S (2000). Factors influencing the low-frequency associated nicotinic ACh autoreceptor-mediated depression of ACh release from rat motor nerve terminals. Br J Pharmacol 129, 1067-1074.
27. Prior C, Tian L, Dempster J & Marshall IG (1995). Prejunctional actions of muscle relaxants: Synaptic vesicles and transmitter mobilization as sites of action. General Pharmacol 26, 659-666.
28. Punkt K, Naupert A, Wellner M, Asmussen G, Schmidt C & Buchwalow IB (2002). Nitric oxide synthase II in rat skeletal muscles. Histochem Cell Biol 118, 371-379.
29. Rameau GA, Chiu L-Y & Ziff EB (2003). NMDA receptor regulation of nNOS phosphorylation and induction of neuron death. Neurobiol Aging 24, 1123-1133.
30. Rathouz MM & Berg DK (1994). Synaptic-type acetylcholine receptors raise intracellular calcium levels in neurons by two mechanisms. J Neurosci 14, 6935-6945.
31. Ribera J, Marsal J, Casanovas A, Hukkanen M, Tarabal O & Esquerda JE (1998). Nitric oxide synthase in rat neuromuscular junctions and in nerve terminals of Torpedo electric organ: Its role as regulator of acetylcholine release. J Neurosci Res 51, 90-102.
32. 2+ responses resistant to muscarinic antagonists at perisynaptic Schwann cells of the frog neuromuscular junction. J Physiol 504, 337-347.
33. Salpeter MM & Loring RH (1985). Nicotinic acetylcholine receptors in vertebrate muscle: Properties, distribution and neural control. Prog Neurobiol 25, 297-325.
34. Schuman EM & Madison DV (1994). Nitric oxide and synaptic function. Annu Rev Neurosci 17, 153-183.
35. Stamler JA & Meissner G (2001). Physiology of nitric oxide in skeletal muscle. Physiol Rev 81, 209-237.
36. 2+- and calmodulin-dependent protein phosphatase: probable identity with calcineurin (CaM-BP80). FEBS Lett 137, 80-84.
37. Thomas S & Robitaille R (2001). Differential frequency-dependent regulation of transmitter release by endogenous nitric oxide at the amphibian neuromuscular junction. J Neurosci 21, 1087-1095.
38. Tian L, Prior C, Dempster J & Marshall I (1997). Hexamethonium- and methyllycaconitine-induced changes in acetylcholine release from rat motor nerve terminals. Br J Pharmacol 122, 1025-1034.
39. Torii N, Kamishita T, Otsu Y & Tsumoto T (1995). An inhibitor for calcineurin, FK506, blocks induction of long-term depression in rat visual cortex. Neurosci Lett 185, 1-4.
40. Tsuneki H, Kimura I, Dezaki K, Kimura M, Sala C & Fumagalli G (1995). Immunohistochemical localization of neuronal nicotinic receptor subtypes at the pre- and postjunctional sites in mouse diaphragm muscle. Neurosci Lett 196, 13-16.
41. Vernino S, Rogers M, Radcliffe K & Dani J (1994). Quantitative measurement of calcium flux through muscle and neuronal nicotinic acetylcholine receptors. J Neurosci 14, 5514-5524.
42. 2+. Neuron 8, 353-362.
43. Wang M-X, Murrell DF, Szabo C, Warren RF, Sarris M & Murrell GAC (2001). Nitric oxide in skeletal muscle: inhibition of nitric oxide synthase inhibits walking speed in rats. Nitric Oxide 5, 219-232.
44. Wang T, Xie Z & Lu B (1995). Nitric oxide mediates activity-dependent synaptic suppression at developing neuromuscular synapses. Nature 374, 262-266.
45. Yang CC, Alvarez RB, Engel WK, Haun CK & Askanas V (1997). Immunolocalization of nitric oxide synthases at the postsynaptic domain of human and rat neuromuscular junctions - light and electron microscopic studies. Exp Neurol 148, 34-44.
46. Yasuda H, Higashi H, Kudo Y, Inoue T, Hata Y, Mikoshiba K & Tsumoto T (2003). Imaging of calcineurin activated by long-term depression-inducing synaptic inputs in living neurons of rat visual cortex. Eur J Neurosci 17, 287-297.